Novel Detection and Clinical Utility of Serum-Derived Extracellular Vesicle in Angiosarcoma
Acta Dermato-Venereologica · 2025
DOI: 10.2340/actadv.v105.40902 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Dermato-Venereologica, 2025. Verfasst von Kazunori Yokoi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan. Hauptthemen laut MEDLINE: Hemangiosarcoma, Extracellular Vesicles, Biomarkers, Tumor, Skin Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Cutaneous angiosarcoma is a rare and highly aggressive skin malignancy. The aim of this study is to explore the alteration of serum-derived extracellular vesicle (EV) in angiosarcoma patients and to evaluate its clinical utility as a novel circulating biomarker. In a microarray analysis to examine the differential expression of specific EV-associated microRNAs in sera between cutaneous angiosarcoma patients and healthy controls, 73 microRNAs with significant upregulation and 100 microRNAs with significant downregulation, respectively, were identified in patients with angio-sarcoma. Among them, quantitative PCR confirmed that miR-184, miR-3925-5p, miR-3926, and miR-5703 were upregulated in sera of cutaneous angiosarcoma patients compared with those of healthy controls and melanoma patients. Additionally, these 4 microRNAs were expressed more highly in angiosarcoma cell lines compared with normal human endothelial cell lines and were prone to elevate along with disease progression. Furthermore, a gene analysis predicted that the target gene set of microRNAs might affect the regulation of TP53 via the epigenetic regulation of MECP2. Taken together, these 4 extracellular vesicle-associated microRNAs in circulation serve as a promising liquid biomarker to identify angiosarcoma patients and trace disease progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan.
- Department of Molecular and Cellular Medicine, Institute of Medical Science, Tokyo Medical University, Tokyo, Japan.
- Department of Dermatology, Tsukuba University, Tsukuba, Ibaraki, Japan.
- Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan. tanemura@derma.med.osaka-u.ac.jp.
ORCID-Profile: Kazunori Yokoi, Atsushi Tanemura
Zitieren
APA
Yokoi, K., Wang, J., Yoshioka, Y., Fujisawa, Y., Fujimoto, M., Ochiya, T., & Tanemura, A. (2025). Novel Detection and Clinical Utility of Serum-Derived Extracellular Vesicle in Angiosarcoma. Acta Dermato-Venereologica. https://doi.org/10.2340/actadv.v105.40902
Vancouver
Yokoi K, Wang J, Yoshioka Y, Fujisawa Y, Fujimoto M, Ochiya T, et al. Novel Detection and Clinical Utility of Serum-Derived Extracellular Vesicle in Angiosarcoma. Acta Dermato-Venereologica. 2025. doi:10.2340/actadv.v105.40902
BibTeX
@article{Yokoi2025,
author = {Yokoi, Kazunori and Wang, Jing and Yoshioka, Yusuke and Fujisawa, Yasuhiro and Fujimoto, Manabu and Ochiya, Takahiro and Tanemura, Atsushi},
title = {Novel Detection and Clinical Utility of Serum-Derived Extracellular Vesicle in Angiosarcoma},
journal = {Acta Dermato-Venereologica},
year = {2025},
doi = {10.2340/actadv.v105.40902}
}
EUVIMED